Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is
commencing today, through a subsidiary, a cash tender to purchase all
outstanding shares of common stock of Cubist Pharmaceuticals, Inc.
(NASDAQ:CBST). On Dec. 8, 2014, Merck announced its intent to acquire
Cubist.
Language:
English
Contact:
MerckMedia:Lainie Keller, 908-236-5036Steve Cragle, 908-740-1801orInvestors:Joe Romanelli, 908-740-1986Justin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
Ticker: CBST Exchange: NASDAQ
read more